Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.

CONCLUSION: Given the high SXT resistance rate, SXT is not an effective first-line therapy for our patients; instead, levofloxacin could be used as an appropriate therapeutic option against S. maltophilia infections.
PMID: 28771141 [PubMed - as supplied by publisher]

Source: Journal of Medical Microbiology - August 4, 2017 Category: Microbiology Authors: Herrera-Heredia SA, Pezina-Cantú C, Garza-González E, Bocanegra-Ibarias P, Mendoza-Olazarán S, Morfín-Otero R, Camacho-Ortiz A, Villarreal-Treviño L, Rodríguez-Noriega E, Paláu-Davila L, Maldonado-Garza HJ, Flores-Treviño S Tags: J Med Microbiol Source Type: research